Study Stopped
Due to the outbreak COVID-19 in our country, the patients coming to our hospital drastically decreased. We could hardly enroll participants due to the paucity of our patients for more than six months, so we decided to withdrawn this study.
Focused Extracorporeal Shock Wave Therapy (ESWT) Versus Traditional Physiotherapy in the Treatment of Trigger Finger
1 other identifier
interventional
N/A
0 countries
N/A
Brief Summary
Trigger finger is the common name of stenosing tenosynovitis of fingers, caused by repetitive trauma. Conservative treatment includes NSAIDs or other analgesic agents, activity modification, splint, and physiotherapy. Operation could be considered if conservative treatments fails. With literature reviewed, there is no treatment which is both non-invasive and effective, and also could avoid recurrence well. Extracorporeal shock wave therapy could induce angiogenesis, anti-inflammatory reaction, and recruitment of fibroblast. Although extracorporeal shock wave has been utilized in musculoskeletal diseases for more than twenty years, there is no well-designed clinical trial to prove the effectiveness of extracorporeal shock wave in treating trigger finger. The purpose of this study is to compare the effectiveness of extracorporeal shock wave therapy with traditional physical therapy for the management of trigger finger.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
Started May 2021
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
March 10, 2021
CompletedFirst Posted
Study publicly available on registry
April 22, 2021
CompletedStudy Start
First participant enrolled
May 1, 2021
CompletedPrimary Completion
Last participant's last visit for primary outcome
December 31, 2021
CompletedStudy Completion
Last participant's last visit for all outcomes
August 31, 2022
CompletedJuly 25, 2022
July 1, 2022
8 months
March 10, 2021
July 21, 2022
Conditions
Keywords
Outcome Measures
Primary Outcomes (5)
Quinnell stages of triggering
Quinnell stages of triggering classifies the trigger finger using five types during flexion and extension: normal movement (Type 0), uneven movement (Type I), actively correctable (Type II), passively correctable (Type III) and fixed deformity (Type IV).
15 weeks
11-point numeric scale of pain
The 11-point numeric scale of pain requires the patient to rate their pain on a defined scale. 0 is no pain and 10 is the worst pain imaginable.
15 weeks
Chinese quick DASH (disabilities of the Arm, Shoulder, and Hand questionnaire)
This questionnaire is a self-administered region-specific outcome instrument developed as a measure of self-rated upper-extremity disability and symptoms. The investigators chose the first two components: the disability and symptom section (11 items, scored 1-5). The lower score means better condition of upper limbs, and vice versa.
15 weeks
strength of hand grip
The strength of hand grip is to measure the maximum isometric strength of the hand and forearm muscles by a electicial grip strength device.
15 weeks
sonographic image
The investigators would record the characteristics of acquired sonographic images, such like the thickness of finger flexor tendon and A1 pulley, the presence of tendon sheath effusion, and the presence of increased vascularity by Doppler images.
15 weeks
Study Arms (2)
Focused Extracorporeal Shock Wave Therapy (ESWT)
EXPERIMENTAL2000 impulses of 5 Hz and 0.32 mJ/mm2 , twice per week for 3 weeks
Physiotherapy
ACTIVE COMPARATORtherapeutic ultrasound, 12 times in 3 weeks
Interventions
2000 impulses of 5 Hz and 0.32 mJ/mm2 , twice per week for 3 weeks
Eligibility Criteria
You may qualify if:
- Quinnel classification grade 2 or 3
- who has only one trigger
You may not qualify if:
- who had ever treated the trigger finger
- who has other musculoskeletal disease of the upper limb
- who has severe coagulopathy disease
- who is pregnant
- who has arrhythmia or has a pacemaker
- there is sensory impairment, scar, edema at the trigger finger
- who has cognitive dysfunction
Contact the study team to confirm eligibility.
Sponsors & Collaborators
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- DOUBLE
- Who Masked
- INVESTIGATOR, OUTCOMES ASSESSOR
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
March 10, 2021
First Posted
April 22, 2021
Study Start
May 1, 2021
Primary Completion
December 31, 2021
Study Completion
August 31, 2022
Last Updated
July 25, 2022
Record last verified: 2022-07